<DOC>
	<DOCNO>NCT02405793</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy low dose high dose Meloxicam SoluMatrix® Capsules versus Meloxicam Tablets treatment pain due osteoarthritis knee hip .</brief_summary>
	<brief_title>Meloxicam SoluMatrix® Capsules v Meloxicam Tablets Treat Osteoarthritis Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Primary diagnosis Functional Class IIII osteoarthritis ( OA ) hip knee Chronic user nonsteroidal antiinflammatory drug ( NSAIDs ) and/or acetaminophen OA pain Discontinued analgesic therapy Screening For woman childbearing potential : woman pregnant nursing , practice acceptable method birth control Ability ambulate History allergic reaction clinically significant intolerance acetaminophen , aspirin , NSAIDs , include meloxicam Requires regular ( 2 dos per week ) use opioid opioid combination product control OA pain knee hip Clinically significant unstable cardiac , respiratory , neurological , immunological , hematological , renal disease Significant difficulties swallow capsules/tablets unable tolerate oral medication Previous participation another clinical study Meloxicam Capsules receive investigational drug device investigational therapy within 30 day Screening</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>